Trial intelligence / Profile preview

Dietary Nitrate for Vaccine-Induced Vascular Dysfunction

NCT02715635Phase 1Completed

Sponsor
Queen Mary University of London
Start
Apr 2016
Primary completion
Dec 2020
Countries
1
01

Overview

Phase 1, randomised, double-blind trial (2 arms), sponsored by Queen Mary University of London. Primary endpoints: Flow mediated dilatation at Day 8 and Plasma nitrite concentration at Day 8. Started Apr 2016; status: completed.

Beyond the preview

Go deeper on NCT02715635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02715635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call